Instil Bio Stock Performance
| TIL Stock | USD 26.15 1.39 5.61% |
Instil Bio holds a performance score of 10 on a scale of zero to a hundred. The company retains a Market Volatility (i.e., Beta) of 5.23, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Instil Bio will likely underperform. Use Instil Bio downside variance, as well as the relationship between the accumulation distribution and market facilitation index , to analyze future returns on Instil Bio.
Risk-Adjusted Performance
10 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Instil Bio are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite quite unfluctuating forward indicators, Instil Bio disclosed solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 5.61 | Five Day Return (1.32) | Year To Date Return 236.55 | Ten Year Return (95.05) | All Time Return (95.05) |
Last Split Factor 1:20 | Last Split Date 2023-12-08 |
1 | Acquisition by Vivo Capital Ix, Llc of 477091 shares of Instil Bio subject to Rule 16b-3 | 09/04/2024 |
2 | Instil Bio and ImmuneOnco Announce Global Registrational Strategy for PD-L1xVEGF Bispecific Antibody, SYN-2510IMM2510, in Non-Small Cell Lung Cancer and Triple-... | 09/16/2024 |
3 | Acquisition by Bronson Crouch of 50000 shares of Instil Bio at 66.1 subject to Rule 16b-3 | 09/18/2024 |
4 | Disposition of 11709696 shares by Vivo Capital Ix, Llc of Instil Bio subject to Rule 16b-3 | 09/20/2024 |
5 | 2 Stocks Up Over 700 percent in 2024 That Could Soar Even Further | 09/25/2024 |
6 | Baird maintains price target on Instil Bio stock, stays upbeat - Investing.com | 10/11/2024 |
7 | Acquisition by Shah Nimish P of 10470 shares of Instil Bio at 20.0 subject to Rule 16b-3 | 10/21/2024 |
8 | Analysis of Curative Ventures V LLCs Strategic Reduction in Instil Bio Inc | 10/23/2024 |
9 | INVITATION TIL DFDS 3. KVT. 2024 TELEKONFERENCE | 11/04/2024 |
10 | Obsidian Therapeutics to Present Preclinical Data Supporting OBX-115 and cytoDRiVE Platform at the Society for Immunotherapy of Cancer Annual Meeting 2024 | 11/05/2024 |
11 | Instil Bio files for 200M mixed securities shelf | 11/13/2024 |
12 | Acquisition by Shah Nimish P of 430431 shares of Instil Bio subject to Rule 16b-3 | 11/21/2024 |
| Begin Period Cash Flow | 43.7 M |
Instil |
Instil Bio Relative Risk vs. Return Landscape
If you would invest 1,287 in Instil Bio on August 27, 2024 and sell it today you would earn a total of 1,328 from holding Instil Bio or generate 103.19% return on investment over 90 days. Instil Bio is generating 2.1244% of daily returns assuming volatility of 16.2104% on return distribution over 90 days investment horizon. In other words, majority of equities are less volatile than Instil, and most equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Instil Bio Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Instil Bio's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Instil Bio, and traders can use it to determine the average amount a Instil Bio's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1311
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | TIL | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 16.21 actual daily | 96 96% of assets are less volatile |
Expected Return
| 2.12 actual daily | 42 58% of assets have higher returns |
Risk-Adjusted Return
| 0.13 actual daily | 10 90% of assets perform better |
Based on monthly moving average Instil Bio is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Instil Bio by adding it to a well-diversified portfolio.
Instil Bio Fundamentals Growth
Instil Stock prices reflect investors' perceptions of the future prospects and financial health of Instil Bio, and Instil Bio fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Instil Stock performance.
| Return On Equity | -0.49 | ||||
| Return On Asset | -0.12 | ||||
| Current Valuation | 135.64 M | ||||
| Shares Outstanding | 6.53 M | ||||
| Price To Earning | 18.31 X | ||||
| Price To Book | 0.97 X | ||||
| Price To Sales | 55,330 X | ||||
| Gross Profit | 138 K | ||||
| EBITDA | (146.12 M) | ||||
| Net Income | (156.09 M) | ||||
| Cash And Equivalents | 354.61 M | ||||
| Cash Per Share | 2.73 X | ||||
| Total Debt | 86.05 M | ||||
| Debt To Equity | 0.12 % | ||||
| Current Ratio | 8.51 X | ||||
| Book Value Per Share | 34.72 X | ||||
| Cash Flow From Operations | (82.03 M) | ||||
| Earnings Per Share | (11.56) X | ||||
| Market Capitalization | 170.65 M | ||||
| Total Asset | 325.63 M | ||||
| Retained Earnings | (580.98 M) | ||||
| Working Capital | 150.2 M | ||||
About Instil Bio Performance
By examining Instil Bio's fundamental ratios, stakeholders can obtain critical insights into Instil Bio's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Instil Bio is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.48) | (0.50) | |
| Return On Capital Employed | (0.51) | (0.53) | |
| Return On Assets | (0.48) | (0.50) | |
| Return On Equity | (0.69) | (0.66) |
Things to note about Instil Bio performance evaluation
Checking the ongoing alerts about Instil Bio for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Instil Bio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Instil Bio is way too risky over 90 days horizon | |
| Instil Bio appears to be risky and price may revert if volatility continues | |
| Instil Bio has high likelihood to experience some financial distress in the next 2 years | |
| Reported Net Loss for the year was (156.09 M) with profit before taxes, overhead, and interest of 138 K. | |
| Instil Bio has about 354.61 M in cash with (82.03 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.73. | |
| Instil Bio has a very weak financial position based on the latest SEC disclosures | |
| Over 81.0% of the company shares are owned by institutional investors | |
| Latest headline from MacroaxisInsider: Acquisition by Shah Nimish P of 430431 shares of Instil Bio subject to Rule 16b-3 |
- Analyzing Instil Bio's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Instil Bio's stock is overvalued or undervalued compared to its peers.
- Examining Instil Bio's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Instil Bio's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Instil Bio's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Instil Bio's stock. These opinions can provide insight into Instil Bio's potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Instil Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy Instil Stock please use our How to buy in Instil Stock guide.You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Instil Bio. If investors know Instil will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Instil Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (11.56) | Return On Assets (0.12) | Return On Equity (0.49) |
The market value of Instil Bio is measured differently than its book value, which is the value of Instil that is recorded on the company's balance sheet. Investors also form their own opinion of Instil Bio's value that differs from its market value or its book value, called intrinsic value, which is Instil Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Instil Bio's market value can be influenced by many factors that don't directly affect Instil Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Instil Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Instil Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Instil Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.